Prosthetic valve endocarditis caused by Campylobacter fetus: a case report and literature review

Ayeong Bak1, Taek Soo Kim1,2, Hyunwoong Park2,3

  • 1Department of Laboratory Medicine, Seoul National University Hospital, Seoul, Republic of Korea.

Insights

Campylobacter fetus, a bacterium, rarely causes prosthetic valve endocarditis (PVE). This case report details a fatal PVE infection, emphasizing the need to consider C. fetus in diagnosing prosthetic valve infections.

Area of Science:

  • Infectious Diseases
  • Cardiology
  • Microbiology

Background:

  • Prosthetic valve endocarditis (PVE) is a severe complication of valve replacement surgery.
  • Campylobacter fetus is a Gram-negative bacillus typically linked to bacteremia in immunocompromised individuals.

Approach:

  • This study presents a rare case of PVE caused by Campylobacter fetus.
  • Diagnostic methods included matrix-assisted laser desorption ionization time-of-flight mass spectrometry and 16S rRNA sequencing.
  • Treatment involved antibiotics (gentamicin and imipenem) and valve replacement surgery.

Key Points:

  • Campylobacter fetus was identified as the causative agent of PVE in a patient with prosthetic heart valves.
  • Despite treatment and surgery, the patient experienced a cardiac arrest and ultimately died.
  • This is the first reported case of C. fetus PVE in Korea.

Conclusions:

  • This case underscores the importance of considering Campylobacter fetus as a potential pathogen in prosthetic valve endocarditis.
  • Early recognition and appropriate treatment are crucial, although outcomes can be severe.
  • The findings suggest C. fetus can cause PVE even in patients without typical risk factors.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...